TO THE EDITOR
The experiments performed by Dr Honczarenko et al 1 confirmed our initial observations that C3 cleavage fragments (C3a and desArg C3a) modulate the responsiveness of hematopoietic cells to an SDF-1 gradient. 2, 3 Accordingly, C3 cleavage fragments primed the responsiveness not only of bone marrow-derived Sca-1 þ cells but interestingly also bone marrow-derived Blymphocytic cells purified at different levels of development. Furthermore, in their letter, the authors supported our hypothesis 4 that not C5L2 but another C3a and desArg C3a binding receptor may be involved in this phenomenon.
Generally, it is widely accepted that while the seven transmembrane-span G-protein coupled C3aR binds anaplylatoxin C3a, its degradation product desArg C3a binds to another unidentified receptor and the seven-transmembrane span C5L2 orphan receptor was postulated to be a possible candidate for this latter interaction. 5 This explains why we have phenotyped early hematopoietic cells for expression of C5L2 mRNA and found that this putative desArg C3a receptor is expressed by these cells. 4 However, based on our observations that blockade of C3aR by C3aR antagonist SB290157 only partially inhibited the priming effect, and not only C3a but also desArg C3a primes responsiveness of hematopoietic stem/progenitor cells (HSPC) to an SDF-1 gradient, 4 we envisioned that another C3a/ desArg C3a binding receptor may exist, which could be responsible for the observed priming effect. This was additionally supported by the data that cells from mice with C3aR knocked out show a priming effect both to C3a and desArg C3a. 4 However, since we did not have access to C5L2 knockout mice and no inhibitor or blocking antibodies against C5L2 were available, we could not directly address the involvement of C5L2 in this phenomenon. 4 Thus, we read with a great deal of interest the letter by Dr Honczarenko's group, who in order to better address this issue took advantage of the C5L2 knockout mice. Their letter to Leukemia 1 supports our concept that C3 cleavage fragments emerge as important regulators of SDF-1-dependent trafficking of HSPC and B-lymphocytes, and by increasing incorporation of CXCR4 into membrane lipid rafts increase responsiveness of HSPC to an SDF-1 gradient. ? Figure 1 Schematic diagram of the hypothetical role of C3 cleavage fragments (C3a and desArg C3a) in sensitizing responsiveness of HSPC to an SDF-1 gradient. C3 is activated in BM in response to marrow damage (eg after conditioning for transplantation by TBI or chemotherapy). [2] [3] [4] Cleavage/activation of C3 in the BM micorenvironment is initiated by a C3-convertase to generate C3a anaphylatoxin. Subsequently, C3a is quickly cleaved by carboxypeptidases, which remove the terminal arginine residue from the 78 amino-acid C3a molecule. Although C3a has a short half-life, the C3a inactivation product, desArg C3a has a long half-life. We postulate that C3a and desArg C3a fragments increase the responsiveness of HSPC to SDF-1 gradients by enhancing incorporation of CXCR4 into membrane lipid rafts. [2] [3] [4] 6 The recent observation 1 supports the concept that while the seven transmembrane-span G-protein coupled C3aR binds C3a only, another nonidentified receptor binds both C3a and desArg C3a. Activation of both of these receptors enhances incorporation of CXCR4 into membrane lipid rafts and thus its better association with downstream signaling proteins. The gene TP73 has been identified as a homologue of tumour suppressor TP53 and is expressed from 1p36, a region frequently deleted in human cancers. 1 TP73 is expressed from two distinct promoters, which results in TAp73 and DNp73 isoforms. TAp73 isoforms contain a transactivation domain and are able to act as transcription factors and transactivate p53 target genes like p21 WAF1/Cip1 and 14-3-3s. DNp73 isoforms lack the transactivation domain and can inhibit the function of TAp73 isoforms and p53. TP73 also presents a wide array of C-terminal splice variants called a, b, g, d, e, Z and z. The resulting p73 proteins have different biological functions and are involved in development, apoptosis, cell-cycle arrest and oncogenesis. Several types of leukemia and solid tumours express much higher levels and alternative combinations of p73 splice variants compared to the tissue from which they originated.
1,2 Hence, the identification of all possible splice variants is essential to fully understand the involvement of TP73 in carcinogenic transformation. However, contrasting results regarding p73 mRNA expression in haematopoietic malignancies obtained by different investigators have been noted. 2 RT-PCR is a simple and easy method that has been frequently used to identify C-terminal p73 splice variants expressed in various human cell types and tissues. By choosing PCR primers outside the region spliced out, several p73 forms can be identified simultaneously. [3] [4] [5] [6] Based on results obtained Figure 1 (a) RT-PCR analysis of C-terminal p73 splice variants in SCC15 cDNA. PCR was performed with primers in exons 8 and 14 of p73, 4 using 1 ng of plasmids pcDNA3TAp73a, pcDNA3TAp73g, pcDNA3TAp73d and increasing amounts (2, 4, 6 or 8 ml) of SCC15 cDNA as template. SCC15 cells were cultured at 371C under 5% CO 2 in DMEM/F12 (ratio 3:1) supplemented with 5% foetal bovine serum (HyClone) and 0.4 mg/ml hydrocortisone (Sigma). RNA was isolated with TRIzol s (invitrogen) and in RT reactions Super-RT (Sphaero Q) was used as described by the manufacturers. PCR was carried out for 35 cycles (20 s, 941C; 30 s, 531C; 1 min, 721C) after a 10 min 'hot start' at 941C and followed by final elongation at 721C for 5 min. The reaction mixture contained 20 pmol of each primer, 1.25 units of AmpliTaqGOLDt (Roche) and 1.5 mM MgCl 2 in a total volume of 50 ml. Control PCR products were run on a 1% agarose gel together with SCC15 cDNA PCR products. DNA was transferred to Hybond-N (Amersham) and hybridised with a p73 specific probe. HaCaT (immortal keratinocyte cell line) and HeLa cells (cervix carcinoma) were cultured in DMEM supplemented with 10% foetal bovine serum. HCT116 cells (colorectal carcinoma) were cultured in RPMI1640 supplemented with 10% foetal bovine serum (Hyclone). Primary human keratinocytes were isolated from foreskin derived from circumcision and grown in serum-free medium (KSFM; Gibco). Primary human fibroblasts were grown in DMEM/F10 in a 1:1 ratio, supplemented with 10% foetal bovine serum (Hyclone). All cells were grown at 371C under 5% CO 2 . The controls for p73a, p73g and p73d are the same as in Figure 1a . The control band for p73Z is the 221 bp PCR product of SCC15 cells. The p73 specific probe was made by digestion with Afl3 (exon 9) of a PCR product with 5 0 -GTCACCGGCAGGCAGAGC (exon 6) and 5 0 -GCTCT CTTTCAGCTTCATCAGG (exon 10) on pcDNA3p73a (the largest fragment was used as probe).
